The procurement provides a nanoassay platform for protein separation and analysis. The instrument will be part of ongoing research on identification and validation of candidate molecules that play key roles in various diseases and can serve as targets for therapy or diagnostic markers. Validation in clinical samples is a final step in the process of biomarker development and the intended procurement will provide a fast, standardized, automated process to do so, removing user variability and providing a nanoscale assay thus saving precious clinical material.
Piesakieties Mercell un saņemiet paziņojumus par jaunākajiem iepirkumiem sev svarīgajās nozarēs 7 dienas bez maksas!